US › Healthcare

Tiziana Life Sciences Ltd (TLSA)

US · Healthcare · Biotechnology

$0.97-0.18%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit

$-12.8M

Profit YoY

-37.5%

EPS

$-0.05

EPS estimate

$0.00

Key statistics

Market cap

$131.1M

Forward P/E

0.0

P/B

2,532.95

Book value

$0.08

EPS (TTM)

$-0.16

52-week high

$2.53

52-week low

$0.87

50-day MA

$1.19

200-day MA

$1.44

Beta

0.44

Analyst view

with an average price target of $9.02.

Shareholding

Insiders

47.65%

Institutions

3.24%

Largest institutional holders

Fund	Stake
Dauntless Investment Group, LLC	1.70%
Mid-American Wealth Advisory Group, Inc.	0.25%
Marshall Wace Asset Management Ltd	0.12%
Zhang Financial LLC	0.09%
UBS Group AG	0.08%
The Colony Group LLC	0.06%
Geode Capital Management, LLC	0.06%
The Goldman Sachs Group Inc	0.06%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tiziana Life Sciences Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.